Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F/β-amyloid precursor protein and Alzheimer's disease

Journal of Neuroscience

Volumn 16, Issue 18, 1996, Pages 5795-5811

  Masliah, Eliezer ^a,b   Sisk, Abbyann ^a   Mallory, Margaret ^a   Mucke, Lennart ^c   Schenk, Dale ^d   Games, Dora ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLADSTONE INSTITUTES   (United States)

^d Athena Neurosciences Inc   (United States)

Author keywords

Alzheimer's disease; amyloid precursor protein; confocal microscopy; electron microscopy; neurodegeneration; transgenic

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; PLATELET DERIVED GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DYSTROPHY; HUMAN; HUMAN TISSUE; MOUSE; NEURITE; NEUROFILAMENT; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENIC MOUSE;

EID: 0029813177     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-18-05795.1996     Document Type: Article

References (75)

1. Bonhomme V, Hans P, Collette J, Moonen G (1993) Neuron-specific enolase as a marker of in vitro neuronal damage. II. Investigation of the astrocyte protective effect against kainate-induced neurotoxicity. J Neurosurg Anesthesiol 5:117-120.
2. Campbell G, Lieberman AR, Anderson PN, Turmaine M (1992) Regeneration of adult rat CNS axons into peripheral nerve autografts: ultrastructural studies of the early stages of axonal sprouting and regenerative axonal growth. J Neurocytol 21:755-787.
3. Chartier-Harlin M-C, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353:844-846.
4. Clark RF, Goate AM (1993) Molecular genetics of Alzheimer's disease. Arch Neurol 50:1164-1172.
5. Cork LC, Masters C, Beyreuther K, Price DL (1990) Development of senile plaques: relationships of neuronal abnormalities and amyloid deposits. Am J Pathol 137:1383-1392.
6. Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G (1991) Senile plaque neurites in Alzheimer's disease accumulate amyloid precursor protein. Proc Natl Acad Sci USA 88:7552-7556.
7. Deftos LJ, Burton DW, Brandt DW (1993) Parathyroid hormone-like protein is a secretory product of atrial myocytes. J Clin Invest 92:727-735.
8. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SC (1988) Alzheimer's disease: a double immunohistochemical study of senile plaques. Am J Pathol 132:86-101.
9. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB, Mee E (1995) In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NcuroReport 6:1053-1057.
10. Forloni G, Chiesa R, Smiroldo S, Verga L, Salmona M, Tagliavini F, Angeretti N (1993) Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. NeuroReport 4:523-526.
11. Frackowiak J, Wisniewski HM, Wegiel J, Merz GS, Iqbal K, Wang KC (1992) Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol 84:225-233.
12. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemes J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995a) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
13. Games D, Carr T, Guido T, Khan K, Soriano F, Tan H, McConlogue L, Lieberburg I, Schenk D, Masliah E (1995b) Progression of Alzheimer-type neuropathology in PDAPP 717 V→F transgenic mice. Soc Neurosci Abstr 21:258.
14. Gheuens J, Cras P, Perry G, Boons J, Ceuterick-de Groote C, Lubke U, Mercken M, Tabaton M, Ganbetti PL, Vandermeeren M (1991) Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases. Brain Res 558:43-52.
15. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Guiffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704.
16. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255:728-730.
17. Gonatas NK, Anderson WW, Evangelista I (1967) The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's disease. J Neuropathol Exp Neurol 26:25-39.
18. Heinonen O, Soininen H, Sorvari H, Kosunene O, Paljarvi L, Koivisto E, Riekkinen PJ (1995) Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 64:375-384.
19. Higgins LS, Holtzman DM, Rabin J, Mobley WC, Cordell B (1994) Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann Neurol 35:598-607.
20. Hirano A (1994) Hirano bodies and related neuronal inclusions. Neuropathol Appl Neurobiol 20:3-11.
21. Hof PR, Cox K, Morrison JH (1990) Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease. I. Superior frontal and inferior temporal cortex. J Comp Neurol 301:44-54.
22. Hyman BT, VanHoesen GW, Damasio AR, Barnes CL (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168-1170.
23. Joachim CL, Mori H, Selkoe DJ (1989) Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature 341:226-230.
24. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet 9:21-30.
25. Lampert P (1967) A comparative electron microscopic study of reactive, degenerating, regenerating, and dystrophic axons. J Neuropathol Exp Neurol 26:345-368.
26. Lassman H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89:35-41.
27. Martin LJ, Pardo CA, Cork LC, Price DL (1994) Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol 145:1358-1381.
28. Masliah E, Hansen L, Albright T, Mallory M, Terry RD (1991a) Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Acta Neuropathol 81:428-433.
29. Masliah E, Mallory M, Hansen L, Alford M, Albright T, DeTeresa R, Terry RD, Baudier J, Saitoh T (1991b) Patterns of aberrant sprouting in Alzheimer's disease. Neuron 6:729-739.
30. Masliah E, Mallory M, Hansen L, Alford M, Albright T, Terry R, Shapiro P, Sundsmo M, Saitoh T (1991c) Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease. Acta Neuropathol 83:12-20.
31. Masliah E, Ellisman M, Carragher B, Mallory M, Young S, Hansen L, DeTeresa R, Terry RD (1992) Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer's disease. J Neuropathol Exp Neurol 51:404-414.
32. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R (1993a) An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol 142:871-882.
33. Masliah E, Mallory M, Deerinck T, DeTeresa R, Lamont S, Miller A, Terry RD, Carragher B, Ellisman M (1993b) Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. J Neuropathol Exp Neurol 52:619-632.
34. Masliah E, Mallory M, Ge N, Godson C, Saitoh T (1993c) Phorbol ester-induced neuritic alterations in the rat neocortex: structural and immunocytochemical studies. Mol Chem Neuropathol 20:125-145.
35. Masliah E, Honer WG, Mallory M, Voigt M, Kushner P, Terry RD (1994a) Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus. Acta Neuropathol 87:135-142.
36. Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R (1994b) Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 174:67-72.
37. Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10:509-519.
38. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10:243-254.
39. Mucke L, Masliah E, Johnson WB, Ruppe MD, Rockenstein EM, Forss-Petter S, Pietropaolo M, Mallory M, Abraham CR (1994) Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res 666:151-167.
40. Munoz DG (1991) Chromogranin A-like immunoreactive neurites are major constituents of senile plaques. Lab Invest 64:826-832.
41. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254:97-99.
42. Nakagawa Y, Nakamura S, Kase Y, Noguchi T, Ishihara T (1987) Colchicine lesions in the rat hippocampus mimic the laterations of several markers in Alzheimer's disease. Brain Res 408:57-64.
43. Palmer AM, Gershon S (1990) Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J 2745:2752.
44. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Neurotransmitter enzyme abnormalities in senile dementia: CAT and GAD activities in necropsy tissue. J Neurol Sci 34:247-265.
45. Pollard H, Charriaut-Marlangue C, Cantagrel S, Represa A, Robain O, Moreau J, Ben-Ari Y (1994) Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 63:7-18.
46. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE (1995) Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J Neurosci 15:3775-3787.
47. Rockenstein EM, McConlogue L, Tan H, Power M, Masliah E, Mucke L (1995) Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J Biol Chem 270:28257-28267.
48. Roher A, Gray EG, Paula-Barbosa M (1988) Alzheimer's disease: coated vesicles, coated pits and the amyloid-related cells. Proc R Soc Lond [Biol]232:367-373.
49. Schochet SS, Lampert PW, Earle KM (1968) Neuronal changes induced by intrathecal vincristine sulfate. J Neuropathol Exp Neurol 27:645-658.
50. Selkoe DJ (1993) Physiological production of the β-amyloid protein and the mechanisms of Alzheimer's disease. Trends Neurosci 16:403-409.
51. Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC, Oltersdorf T (1988) Beta-amyloid precursor protein of Alzheimer's disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissue. Proc Natl Acad Sci USA 85:7341-7345.
52. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327.
53. Shelansky ML (1969) Neurofibrillary degeneration. Arch Neurol 20:199-206.
54. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248:492-494.
55. Sloviter RS, Dean E, Neubort S (1993) Electron microscopic analysis of adrenalectomy-induced hippocampal granule cell degeneration in the rat: apoptosis in the adult central nervous system. J Comp Neurol 330:337-351.
56. Smale G, Nichols NR, Brady DR, Finch CE, Horton Jr WE (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133:225-230.
57. Southam E, Thomas PK, King RHM, Goss-Sampson MA, Muller DPR (1991) Experimental vitamin E deficiency in rats. Morphological and functional evidence of abnormal axonal transport secondary to free radical damage. Brain 114:915-936.
58. Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 5:2529-2533.
59. Suzuki N, Cheung TT, Cai X-D, Odaka A, Otvos Jr L, Eckman C, Golde TE, Younkin SG (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (beta APP717) mutants. Science 264:1336-1340.
60. Terry RD, Pena C (1965) Experimental production of neurofibrillary degeneration. II. Electron microscopy: phosphatase histochemistry and electron probe analysis. J Neuropathol Exp Neurol 24:200-210.
61. Terry RD, Wisniewski HM (1970) The ultrastructure of the neurofibrillary tangle and the senile plaque. In: Ciba Foundation symposium on Alzheimer's disease and related conditions (Wolstenholme GEW, O'Connor M, eds), pp 145-168. London: J. & A. Churchill.
62. Terry RD, Gonatas NK, Weiss M (1964) Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol 44:269-297.
63. Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10:184-192.
64. Terry RD, Hansen L, Masliah E (1994) Structural alterations in Alzheimer's disease. In: Alzheimer's disease (Terry RD, Katzman R, eds), pp 179-196. New York: Raven.
65. Toggas SM, Masliah E, Rockenstein EM, Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193.
66. Wang D, Munoz DG (1995) Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain. J Neuropathol Exp Neurol 54:548-556.
67. Weiler R, Lassmann H, Fischer P, Jellinger K, Winkler H (1990) A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer's and Pick's disease. FEBS Lett 263:337-339.
68. Wilcock GK, Esiri MM, Bowen DM, Hughes AO (1988) The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type. J Neurol Neurosurg Psychiatry 51:842-849.
69. Wisniewski H, Terry RD (1967) Experimental colchicine encephalopathy. I. Introduction of neurofibrillary degeneration. Lab Invest 17:577-587.
70. Wisniewski H, Terry RD (1970) An experimental approach to the morphogenesis of neurofibrillary degeneration and the argyrophilic plaque. In: Ciba Foundation symposium on Alzheimer's disease and related conditions (Wolstenholme GEW, O'Connor M, eds), pp 223-248. London: J. & A. Churchill.
71. Wisniewski H, Terry RD (1973) Re-examination of the pathogenesis of the senile plaque. In: Progress in neuropathology, Vol 2 (Zimmerman HM, ed), pp 1-26. New York: Grune & Stratton.
72. Wisniewski H, Johnson AB, Paine CS, Kay WJ, Terry RD (1970) Senile plaques and cerebral amyloidosis in aged dogs. Lab Invest 23:287-296.
73. Wisniewski HM, Sinatra RS, Iqbal IY (1981) Neurofibrillary and synaptic pathology in aged brain. In: Aging and cell structure, Vol 1 (Johnson J, ed), pp 105-142. New York: Plenum.
74. Wisniewski HM, Wegiel J, Wang KC, Kujawa M, Lach B (1989) Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci 16:535-542.
75. Wisniewski HM, Barcikowska M, Kida E (1991) Phagocytosis of β/A4 amyloid fibrils of the neuritic neocortical plaques. Acta Neuropathol 81:588-590.